Thursday, 7 May 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 07 May 2026
News

Industry's global jobs purge ongoing

 Posted 7 May 2026 AM

The global downsizing of industry continues with BioNTech, the darling of the COVID-19 pandemic, slashing its manufacturing footprint - and 1860 jobs with it - along with much smaller trims by Gilead and Novartis this week.

In the face of diminishing sales of its Pfizer-partnered Covid vaccine, Comirnaty, BioNTech has decided to shutter manufacturing plants in Singapore and the German cities of Idar-Oberstein and Marburg. In addition, it will close the former headquarters of its CureVac subsidiary, also in Germany.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (8)

Sales & Customer Relations (10)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (4)

Other (9)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.